There’s a large want for revolutionary options for individuals with neurological issues equivalent to A number of Sclerosis, Alzheimer’s illness, Parkinson’s illness, and so on., as 60% of Europeans shall be affected by a mind dysfunction, and the variety of instances is anticipated to extend dramatically within the coming a long time (www.ean.org). On this context, Frost & Sullivan’s analysis means that icometrix is extraordinarily well-positioned to capitalize on new development alternatives, cementing its management within the business of neurology precision drugs.
Frost & Sullivan was extremely impressed with icometrix’s strategy to driving a significant affect by means of real-world proof era in collaboration with suppliers, pharma and particularly its shut work with payers to develop the proof for reimbursement of the expertise, e.g a UK Medtech Innovation Briefing from the Nationwide Institute for Care and Excellence. (NICE) Taken collectively, these shut collaborations are key to capturing the affected person, financial and healthcare worth of the expertise in neurology to drive in the direction of a extra precision drugs strategy.
“Frost & Sullivan is recognised for his or her in-depth unbiased market analyses, so we’re honoured to be receiving this world expertise innovation management award within the area of neurology.”, says Prof. Wim Van Hecke, Ph.D, founder and CEO of icometrix. “We’re particularly happy that Frost & Sullivan highlighted our dedication to driving the affect of our digital platform throughout the worth chain of the care path, as we imagine that’s key to realizing the advantages of a extra precision drugs strategy to neurology”, Prof. Van Hecke concludes.
Frost & Sullivan anticipates speedy, widespread expertise adoption for icometrix’s AI algorithms and commends the corporate’s strategic practices that promote profitable operational affect for the care path.
Learn the total Frost & Sullivan report on icometrix right here.
Based in 2011, icometrix (Leuven, Belgium; Boston, USA) impacts lives of individuals with neurological situations by means of distinctive digital well being AI options, data-driven insights, and personalised affected person care. icometrix’ options are regulatory cleared and seamlessly built-in in hospital techniques. icobrain extracts information from mind MRI and CT scans for the radiological reporting and medical administration of neurological issues equivalent to a number of sclerosis, mind trauma, epilepsy, stroke, dementia, and Alzheimer’s illness. icompanion, a digital platform, and cell app helps individuals with MS and their care workforce to observe medical signs and coverings effectively and objectively. icolung was one of many first obtainable AI options to assist clinicians responding to the quickly evolving wants of the COVID-19 pandemic.
Right this moment, icometrix is internationally energetic and built-in into a whole bunch of medical practices. As well as, icometrix helps main pharmaceutical corporations in de-risking the medical translation of recent neuro therapies with quite a lot of companies that leverage its AI-driven digital well being platform for precision neurology.
BE: +32 16 369 000
US: +1 617 528 0980
Kolonel Begaultlaan 1b / 12
Frost & Sullivan 2022 Expertise Innovation Management Award for icometrix: